The Impact of PDD During TURB for NMIBC

The goal of this clinical trial is to learn if photodynamic diagnosis (PDD) performed using violet light after intra-vesical instillation of hexaminolaevulinic acid (Hexvix 85mg/50ml) is more sensitive than the standard white light tecnique in detection of malignant bladder tumour. Patients will be randomised to: * Transurethral resection of the bladder (TURB) with a standard white light tecnique * TURB with the PDD tecnique using the study drug Hexvix

NCT Number	NCT06548438
Lead Sponsor	A.O.U. Città della Salute e della Scienza Collaborators: Photocure
Conditions	Bladder Cancer
Enrollment	300 participants
Start Date	2024-09-01
Primary Completion	2027-03-31 (estimated)
Study Completion	2027-09-01 (estimated)
Updated on ClinicalTrials.gov	2024-08-12